Sunshine Biopharma Files 8-K Report
Ticker: SBFMW · Form: 8-K · Filed: Jun 11, 2024 · CIK: 1402328
| Field | Detail |
|---|---|
| Company | Sunshine Biopharma, Inc (SBFMW) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
Related Tickers: SBFM
TL;DR
Sunshine Biopharma filed an 8-K, but it's light on details for now.
AI Summary
On June 11, 2024, Sunshine Biopharma, Inc. filed an 8-K report detailing an "Other Event." The company, previously known as Mountain West Business Solutions, Inc., is incorporated in Colorado and headquartered in Fort Lauderdale, Florida. The filing does not disclose specific financial transactions or material events beyond the general "Other Events" category.
Why It Matters
This 8-K filing indicates Sunshine Biopharma has made a regulatory submission, but the lack of specific details means investors cannot yet assess any immediate impact on the company's operations or stock.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate negative or positive financial disclosures, making the risk level low.
Key Players & Entities
- Sunshine Biopharma, Inc. (company) — Registrant
- Mountain West Business Solutions, Inc. (company) — Former Company Name
- June 11, 2024 (date) — Date of Report
- Colorado (jurisdiction) — State of Incorporation
- Fort Lauderdale, FL (location) — Principal Executive Offices
FAQ
What specific event is Sunshine Biopharma reporting in this 8-K filing?
The filing is categorized under 'Other Events' and does not specify the exact nature of the event.
When was this 8-K report filed?
The report was filed on June 11, 2024.
What was Sunshine Biopharma's former company name?
Sunshine Biopharma, Inc. was formerly known as Mountain West Business Solutions, Inc.
In which state is Sunshine Biopharma, Inc. incorporated?
Sunshine Biopharma, Inc. is incorporated in Colorado.
Where are Sunshine Biopharma's principal executive offices located?
The principal executive offices are located at 333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, FL 33301.
Filing Stats: 389 words · 2 min read · ~1 pages · Grade level 9.8 · Accepted 2024-06-11 16:00:38
Key Financial Figures
- $0.001 — ch Registered Common Stock, par value $0.001 SBFM The Nasdaq Stock Market LLC
Filing Documents
- sunshine_8k.htm (8-K) — 25KB
- 0001683168-24-004120.txt ( ) — 236KB
- sbfm-20240611.xsd (EX-101.SCH) — 3KB
- sbfm-20240611_def.xml (EX-101.DEF) — 26KB
- sbfm-20240611_lab.xml (EX-101.LAB) — 36KB
- sbfm-20240611_pre.xml (EX-101.PRE) — 25KB
- sunshine_8k_htm.xml (XML) — 5KB
01. Other Events
Item 8.01. Other Events. As of June 11, 2024, all of the Series A Warrants issued by Sunshine Biopharma, Inc. on February 15, 2024, have been exercised. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: June 11, 2024 SUNSHINE BIOPHARMA, INC. By: /s/ Dr. Steve N. Slilaty Dr. Steve N. Slilaty, Chief Executive Officer 3